Covered recipient · General Payments record
SARA RUSSO
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2022–2024
$4,086.92
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,770.78 | 24 |
| Travel and Lodging | $1,496.31 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $2,142.13 | 16 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $269.23 | 3 |
| UCB, Inc. | $249.79 | 3 |
| GENZYME CORPORATION | $233.64 | 2 |
| Dermavant Sciences, Inc. | $149.50 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122.82 | 1 |
| PFIZER INC. | $99.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $109.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385010 | CMS |
| ABBVIE INC. | $38.04 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385012 | CMS |
| ABBVIE INC. | $41.14 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385014 | CMS |
| ABBVIE INC. | $85.97 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385016 | CMS |
| ABBVIE INC. | $830.97 | 06/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106385018 | CMS |
| ABBVIE INC. | $585.34 | 06/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106385020 | CMS |
| ABBVIE INC. | $125.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385022 | CMS |
| ABBVIE INC. | $125.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385024 | CMS |
| ABBVIE INC. | $33.93 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385026 | CMS |
| ABBVIE INC. | $80.00 | 07/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106385028 | CMS |
| ABBVIE INC. | $25.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385030 | CMS |
| ABBVIE INC. | $25.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385032 | CMS |
| ABBVIE INC. | $7.46 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385034 | CMS |
| ABBVIE INC. | $15.59 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385036 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385038 | CMS |
| ABBVIE INC. | $9.79 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106385040 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122.82 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118101144 | CMS |
| Dermavant Sciences, Inc. | $149.50 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127947092 | CMS |
| GENZYME CORPORATION | $95.34 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139643994 | CMS |
| GENZYME CORPORATION | $138.30 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139644004 | CMS |
| Novartis Pharmaceuticals Corporation | $139.47 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087431180 | CMS |
| Novartis Pharmaceuticals Corporation | $12.50 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087431182 | CMS |
| Novartis Pharmaceuticals Corporation | $117.26 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087431184 | CMS |
| PFIZER INC. | $99.98 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130909741 | CMS |
| UCB, Inc. | $102.73 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143065109 | CMS |
| UCB, Inc. | $18.47 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143065111 | CMS |
| UCB, Inc. | $128.59 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143065113 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.